Genetic tests to identify the most effective psychiatry drugs are the hot new thing in the race to better treat conditions ranging from depression to attention deficit disorder to anxiety. But a review by NECIR has found that virtually all the evidence that these psychiatric tests work is based on limited studies funded by the companies themselves. And unlike drugs, they are not regulated by the FDA.
Join NECIR's Senior Investigative Reporter Beth Daley, Huffington Post Healthy Living Editor Erin Schumaker, Dr. Joseph Goldberg of the Icahn School of Medicine at Mount Sinai, Dr. Daniel Carlat of Tufts University School of Medicine, and Dr. John Grohol of PsychCentral to learn more about this emerging industry in mental health care.
The U.S. Food and Drug Administration has proposed regulation over a broad number of medical tests. But the proposal has the medical industry sharply divided.
NECIR reporter Beth Daley’s examination into examinations of unregulated medical tests – for everything from cancer to Lyme disease to prenatal genetic defects –...
The New England Center for Investigative Reporting won a first place nod for investigative reporting in the Awards for Excellence in Health Care Journalism from the national Association of Health Care Journalists, Executive Director Joe Bergantino announced March 19.
The New England Center for Investigative Reporting took home a prize in the competitive health-care category from the Society of American Business Writers and Editors, the Society announced at their spring conference in Chicago on April 25.
The New England Center for Investigative Reporting has won highest honors from the New England Newspaper & Press Association for stories on faulty prenatal testing and homeowner debt. The 2015 awards, to be presented Oct. 8, will go to the Center’s science reporter, Beth Daley, and Jenifer McKim, who covers social justice issues.